NL1007491C2 - Toepassing van een polyvinylpyrrolidon voor het verminderen van de variatie van de middelomtrek en het effect van constipatie ten gevolge van het innemen van andere stoffen. - Google Patents
Toepassing van een polyvinylpyrrolidon voor het verminderen van de variatie van de middelomtrek en het effect van constipatie ten gevolge van het innemen van andere stoffen. Download PDFInfo
- Publication number
- NL1007491C2 NL1007491C2 NL1007491A NL1007491A NL1007491C2 NL 1007491 C2 NL1007491 C2 NL 1007491C2 NL 1007491 A NL1007491 A NL 1007491A NL 1007491 A NL1007491 A NL 1007491A NL 1007491 C2 NL1007491 C2 NL 1007491C2
- Authority
- NL
- Netherlands
- Prior art keywords
- polyvinylpyrrolidone
- agent
- concentration
- reduce
- use according
- Prior art date
Links
- 229920000036 polyvinylpyrrolidone Polymers 0.000 title claims abstract description 56
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 title claims abstract description 56
- 239000001267 polyvinylpyrrolidone Substances 0.000 title claims abstract description 50
- 206010010774 Constipation Diseases 0.000 title claims abstract description 13
- 230000000694 effects Effects 0.000 title claims description 10
- 239000000126 substance Substances 0.000 title description 3
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 23
- 239000013043 chemical agent Substances 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 21
- 235000013305 food Nutrition 0.000 claims description 16
- 239000004927 clay Substances 0.000 claims description 13
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 229910052901 montmorillonite Inorganic materials 0.000 claims description 9
- 230000001632 homeopathic effect Effects 0.000 claims description 5
- 239000005995 Aluminium silicate Substances 0.000 claims description 3
- 235000012211 aluminium silicate Nutrition 0.000 claims description 3
- 239000000440 bentonite Substances 0.000 claims description 3
- 229910000278 bentonite Inorganic materials 0.000 claims description 3
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 3
- 229910052624 sepiolite Inorganic materials 0.000 claims description 3
- 235000019355 sepiolite Nutrition 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 2
- 229910021647 smectite Inorganic materials 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract description 8
- 229940069328 povidone Drugs 0.000 abstract description 5
- 235000012054 meals Nutrition 0.000 description 14
- 235000015218 chewing gum Nutrition 0.000 description 11
- 229940112822 chewing gum Drugs 0.000 description 10
- 239000002775 capsule Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 239000011230 binding agent Substances 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 206010000060 Abdominal distension Diseases 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229920003072 Plasdone™ povidone Polymers 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000000902 placebo Substances 0.000 description 3
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 229960000892 attapulgite Drugs 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 239000008157 edible vegetable oil Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229910052625 palygorskite Inorganic materials 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 2
- 230000009291 secondary effect Effects 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000006890 Erythroxylum coca Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229940095710 chewable product Drugs 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000008957 cocaer Nutrition 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000002079 cooperative effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- -1 for example Polymers 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/29—Mineral substances, e.g. mineral oils or clays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
- A61K31/79—Polymers of vinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Confectionery (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Steroid Compounds (AREA)
- Graft Or Block Polymers (AREA)
- Photoreceptors In Electrophotography (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9613646A FR2762215A1 (fr) | 1996-11-08 | 1996-11-08 | Utilisation d'un agent chimique pour diminuer l'effet de constipation et le tour de taille |
| FR9613646 | 1996-11-08 | ||
| FR9707693 | 1997-06-20 | ||
| FR9707693 | 1997-06-20 | ||
| FR9709559A FR2762216B1 (fr) | 1997-07-28 | 1997-07-28 | Utilisation d'un agent chimique pour diminuer l'effet de constipation et le tour de taille |
| FR9709559 | 1997-07-28 | ||
| FR9709701A FR2766369B1 (fr) | 1997-07-28 | 1997-07-30 | Utilisation d'un agent chimique pour diminuer l'effet de constipation et le tour de taille |
| FR9709701 | 1997-07-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL1007491A1 NL1007491A1 (nl) | 1998-05-14 |
| NL1007491C2 true NL1007491C2 (nl) | 1999-04-23 |
Family
ID=27446984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL1007491A NL1007491C2 (nl) | 1996-11-08 | 1997-11-07 | Toepassing van een polyvinylpyrrolidon voor het verminderen van de variatie van de middelomtrek en het effect van constipatie ten gevolge van het innemen van andere stoffen. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5948824A (de) |
| EP (1) | EP0959892B1 (de) |
| JP (1) | JP2000514465A (de) |
| AT (1) | ATE232734T1 (de) |
| AU (1) | AU5058698A (de) |
| BE (1) | BE1011385A3 (de) |
| CA (1) | CA2270943A1 (de) |
| CH (1) | CH692467A5 (de) |
| DE (1) | DE69719218D1 (de) |
| IT (1) | IT1295954B1 (de) |
| NL (1) | NL1007491C2 (de) |
| WO (1) | WO1998020883A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2811553B1 (fr) | 2000-07-12 | 2002-09-13 | Oreal | Compositions contenant des composes du type sel de flavylium non substitues en position 3 pour la coloration de la peau et une silicone organomodifiee |
| US6428822B1 (en) | 2001-04-03 | 2002-08-06 | Chengzhi Life Science Company, Ltd. | Extracts of mixed arctium lappa L., carrot and whole radish for treating hypertension, constipation and detoxification |
| DE10120428A1 (de) * | 2001-04-26 | 2002-10-31 | Thomas Gieselmann | Orales Mittel für die Human- und Veterinärmedizin |
| US20030022206A1 (en) * | 2001-05-16 | 2003-01-30 | Kay Robert A. | Method of characterizing a homeopathic preparation |
| JP5298942B2 (ja) * | 2008-02-26 | 2013-09-25 | 大正製薬株式会社 | 飲料 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0273209B1 (de) * | 1986-12-30 | 1992-01-15 | American Cyanamid Company | Zusammensetzung die ein Polycarbophil enthält |
| US5516524A (en) * | 1993-12-20 | 1996-05-14 | The Procter & Gamble Company | Laxative compositions containing bulk fiber |
| US5418220A (en) * | 1994-03-08 | 1995-05-23 | Schmidt; Alfred | Method for treating constipation using dimethicone |
| JP3836893B2 (ja) * | 1995-01-24 | 2006-10-25 | アボットジャパン株式会社 | ポリカルボフィルカルシウム含有製剤 |
-
1997
- 1997-11-07 EP EP97913279A patent/EP0959892B1/de not_active Expired - Lifetime
- 1997-11-07 DE DE69719218T patent/DE69719218D1/de not_active Expired - Lifetime
- 1997-11-07 BE BE9700898A patent/BE1011385A3/fr not_active IP Right Cessation
- 1997-11-07 AT AT97913279T patent/ATE232734T1/de not_active IP Right Cessation
- 1997-11-07 CA CA002270943A patent/CA2270943A1/fr not_active Abandoned
- 1997-11-07 IT IT97TO000974A patent/IT1295954B1/it active IP Right Grant
- 1997-11-07 US US08/965,964 patent/US5948824A/en not_active Expired - Fee Related
- 1997-11-07 JP JP10522237A patent/JP2000514465A/ja not_active Ceased
- 1997-11-07 WO PCT/FR1997/002007 patent/WO1998020883A1/fr not_active Ceased
- 1997-11-07 NL NL1007491A patent/NL1007491C2/nl not_active IP Right Cessation
- 1997-11-07 CH CH02581/97A patent/CH692467A5/fr not_active IP Right Cessation
- 1997-11-07 AU AU50586/98A patent/AU5058698A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IT1295954B1 (it) | 1999-05-28 |
| ATE232734T1 (de) | 2003-03-15 |
| WO1998020883A1 (fr) | 1998-05-22 |
| EP0959892B1 (de) | 2003-02-19 |
| AU5058698A (en) | 1998-06-03 |
| CA2270943A1 (fr) | 1998-05-22 |
| NL1007491A1 (nl) | 1998-05-14 |
| US5948824A (en) | 1999-09-07 |
| EP0959892A1 (de) | 1999-12-01 |
| ITTO970974A1 (it) | 1999-05-07 |
| ITTO970974A0 (it) | 1997-11-07 |
| CH692467A5 (fr) | 2002-07-15 |
| DE69719218D1 (de) | 2003-03-27 |
| JP2000514465A (ja) | 2000-10-31 |
| BE1011385A3 (fr) | 1999-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Singh et al. | Effect on absorption and oxidative stress of different oral Coenzyme Q10 dosages and intake strategy in healthy men | |
| CA2086566A1 (en) | Inhibitor for absorption of digested and decomposed products of food and drink | |
| CN102665725A (zh) | 高血脂症改善剂、贫血改善组合物、尿酸值降低组合物以及饮料食品 | |
| WO1997037672A1 (en) | Biogenic powder preparation comprising ossified reindeer horns and food additive comprising the same | |
| Forsythe et al. | Two controlled trials of tyramine in children with migraine | |
| KR20100074190A (ko) | 세사민류와 비타민 ｂ１ 류를 배합한 조성물 | |
| KR102592353B1 (ko) | 호모해링토닌을 유효성분으로 함유하는 근육질환 예방 또는 치료용 조성물 | |
| RU2145228C1 (ru) | Профилактическое и общеукрепляющее средство широкого спектра действия | |
| JP2006028051A (ja) | 起床時疲労感改善剤、起床時疲労感改善用組成物、及びこれらを含む起床時疲労感改善用飲食物 | |
| US10695317B2 (en) | Composition for promoting production of brain-derived neurotrophic factor | |
| WO2002043752A1 (fr) | Agents therapeutiques de potentialisation d'effet a base d'interferon | |
| US5948824A (en) | Use of a chemical agent for reducing the changes in waistline and the effect of constipation due to the taking of other agents | |
| JP2002187846A (ja) | 組成物及びそれを含有する食品、抗関節炎剤、抗リュウマチ剤又は飼料 | |
| US20100273737A1 (en) | Supplementary food composition for reducing body odor | |
| KR100584153B1 (ko) | 생약소재에 의한 변비 개선용 농축액 및 그 제조방법 | |
| JP3345650B2 (ja) | 高血圧抑制剤 | |
| JPH11147828A (ja) | コレステロール及び脂質吸収阻害剤 | |
| KR100429086B1 (ko) | 장기능 활성효과를 갖는 건강 보조 식품 조성물 | |
| DE602005001849T2 (de) | Orale diätzusammensetzung, enthaltend konjugierte linolsäure und coffein | |
| JPH02283261A (ja) | 多糖体成分含有加工食品又は飲料 | |
| US20020102299A1 (en) | Triglyceride reducing agent | |
| JP2006306897A (ja) | モズク由来フコイダン含有剤 | |
| Rathore et al. | Clinical study to evaluate the efficacy of Indukantam Ghritam (SY) in the management of Balshosha WSR to PEM (Protein Energy Malnutrition) | |
| KR101970353B1 (ko) | 몰루긴 및 bmp-2를 포함하는 골 질환의 예방 또는 치료용 조성물 | |
| Waghmare et al. | Medicinal Effect of Curcumin as an Anti-tuberculosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AD1A | A request for search or an international type search has been filed | ||
| PD2A | A request for search or an international type search has been filed | ||
| VD1 | Lapsed due to non-payment of the annual fee |
Effective date: 20080601 |